Skip to main content

Table 1 Distribution of bacterial species among ESBL-E, pAmpC-E, CIP-RE and CIRE isolates, Northern Cyprus, 2017

From: Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in Enterobacteriaceae: fecal carriage rates and associated risk factors in the community of Northern Cyprus

Bacterial species ESBL-E pAmpC-E CIP-RE CIRE
n/N (%)a n/N (%)a n/N (%)a n/N (%)a
Escherichia coli 101/107 (94.4) 13/15 (86.7) 51/51 (100.0) 2/6 (33.3)
Klebsiella pneumoniae 3/107 (2.8) 2/15 (13.3) 2/6 (33.3)
Klebsiella oxytoca 1/6 (16.7)
Enterobacter cloacae 1/107 (0.9)
Enterobacter aerogenes 1/107 (0.9) 1/6 (16.7)
Providencia rettgeri 1/107 (0.9)
Total n/N (%)b 107/500 (21.4) 15/500 (3.0) 51/500 (10.2) 6/500 (1.2)
  1. Abbreviations: ESBL-E Extended-spectrum β-lactamase-producing Enterobacteriaceae; pAmpC-E plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae, CIP-RE Ciprofloxacin-resistant Enterobacteriaceae, CIRE Carbapenem-intermediate or -resistant Enterobacteriaceae
  2. aIndicates the percentage of bacterial species among ESBL-E (N = 107), pAmpC-E (N = 15), CIP-RE (N = 51), or CIRE (N = 6) isolates
  3. bIndicates the percentage of ESBL-E, pAmpC-E, CIP-RE and CIRE isolates according to 500 samples